Boston Sci's Innova OK'd By FDA To Treat Peripheral Artery Disease
This article was originally published in The Gray Sheet
Executive Summary
The vascular self-expanding stent system has been approved as an advanced treatment for patients with narrowing or blockages in their superficial femoral artery or proximal popliteal artery, which can lead to peripheral artery disease – a condition that affects 8 million Americans.
You may also be interested in...
Corrosion Testing For Nickel Stents Front And Center In FDA Final Update
The agency says it has taken into account feedback from industry during a 2013 workshop on the risks of nickel stents, and has reduced its requirements for standard corrosion testing while also outlining steps on when to adopt different corrosion testing methods.
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.